OWLT vs. AMLX

Last updated Apr 1, 2026

Compare and contrast key facts about Owlet, Inc. (OWLT) and Amylyx Pharmaceuticals, Inc. (AMLX).

Performance

OWLT vs. AMLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Owlet, Inc. (OWLT) and Amylyx Pharmaceuticals, Inc. (AMLX). The values are adjusted to include any dividend payments, if applicable.

OWLT vs. AMLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
OWLT Owlet, Inc.	-68.25%	263.82%	-15.72%	-32.54%	-77.46%
AMLX Amylyx Pharmaceuticals, Inc.	15.07%	219.58%	-74.32%	-60.16%	104.48%

Fundamentals

Market Cap OWLT : $2.89B AMLX : $1.31B
EPS OWLT : -$0.21 AMLX : -$1.57
PB Ratio OWLT : 176.30 AMLX : 4.31
Total Revenue (TTM) OWLT : $105.66M AMLX : $0.00
Gross Profit (TTM) OWLT : $53.51M AMLX : $0.00
EBITDA (TTM) OWLT : -$38.49M AMLX : -$144.16M

Returns By Period

In the year-to-date period, OWLT achieves a -68.25% return, which is significantly lower than AMLX's 15.07% return.

OWLT

• 1D: 13.47%
• 1M: -55.50%
• YTD: -68.25%
• 6M: -39.32%
• 1Y: 39.67%
• 3Y*: 4.21%
• 5Y*: -48.26%
• 10Y*: —

AMLX

• 1D: 8.93%
• 1M: -8.37%
• YTD: 15.07%
• 6M: 2.28%
• 1Y: 292.66%
• 3Y*: -22.04%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

OWLT vs. AMLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OWLT

OWLT Risk / Return Rank: 59
OWLT Sharpe Ratio Rank: 58
OWLT Sortino Ratio Rank: 61
OWLT Omega Ratio Rank: 63
OWLT Calmar Ratio Rank: 56
OWLT Martin Ratio Rank: 60

AMLX

AMLX Risk / Return Rank: 97
AMLX Sharpe Ratio Rank: 99
AMLX Sortino Ratio Rank: 97
AMLX Omega Ratio Rank: 94
AMLX Calmar Ratio Rank: 98
AMLX Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OWLT vs. AMLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Owlet, Inc. (OWLT) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	OWLT	AMLX	Difference
Sharpe ratio Return per unit of total volatility	0.44	4.03	-3.59
Sortino ratio Return per unit of downside risk	1.18	4.16	-2.97
Omega ratio Gain probability vs. loss probability	1.17	1.49	-0.31
Calmar ratio Return relative to maximum drawdown	0.60	10.02	-9.42
Martin ratio Return relative to average drawdown	1.88	23.29	-21.41
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

OWLT vs. AMLX - Sharpe Ratio Comparison

The current OWLT Sharpe Ratio is 0.44, which is lower than the AMLX Sharpe Ratio of 4.03. The chart below compares the historical Sharpe Ratios of OWLT and AMLX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	OWLT	AMLX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.44	4.03	-3.59
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.54	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.53	-0.07	-0.46

Correlation

The correlation between OWLT and AMLX is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

OWLT vs. AMLX - Dividend Comparison

Neither OWLT nor AMLX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

OWLT vs. AMLX - Drawdown Comparison

The maximum OWLT drawdown since its inception was -98.14%, roughly equal to the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for OWLT and AMLX.

Drawdown Indicators

	OWLT	AMLX	Difference
Max Drawdown Largest peak-to-trough decline	-98.14%	-96.04%	-2.10%
Max Drawdown (1Y) Largest decline over 1 year	-72.58%	-27.93%	-44.65%
Max Drawdown (5Y) Largest decline over 5 years	-98.06%	—	—
Current Drawdown Current decline from peak	-96.59%	-66.04%	-30.55%
Average Drawdown Average peak-to-trough decline	-77.32%	-59.24%	-18.08%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.16%	12.01%	+11.15%

Volatility

OWLT vs. AMLX - Volatility Comparison

Owlet, Inc. (OWLT) has a higher volatility of 51.87% compared to Amylyx Pharmaceuticals, Inc. (AMLX) at 19.23%. This indicates that OWLT's price experiences larger fluctuations and is considered to be riskier than AMLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	OWLT	AMLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	51.87%	19.23%	+32.64%
Volatility (6M) Calculated over the trailing 6-month period	73.45%	45.20%	+28.25%
Volatility (1Y) Calculated over the trailing 1-year period	90.49%	73.18%	+17.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	89.38%	92.82%	-3.44%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	86.17%	92.82%	-6.65%

Financials